Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Manhattan Scientifics, Inc. (MHTX)
USD0.00
+0.00 (+0.00%)
US OTC Healthcare Medical - Devices
Address
244 Fifth Avenue 10001
New York City, NY, US
New York City, NY, US
CEO
Emmanuel Tsoupanarias
Website
mhtx.com
IPO
1998-01-06
CIK 1099132 ISIN US5631221000
Description
Manhattan Scientifics, Inc. operates as an innovation hub, primarily dedicated to the advancement and market introduction of technologies designed to enhance human life across the United States. The company's specialized efforts are concentrated within the fields of nanotechnology and nanomedicine. Established in 1992 and headquartered in New York City, the firm was formerly known as Grand Enterprises, Inc.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.00
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
35
Beta
9.04
Float Shares
474.16M
Free Float %
84.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -80.00% | +1,900.00% | -80.00% | -80.00% | -80.00% | -99.52% | -99.92% | -99.97% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.00
DCF (Levered)
0.00
-37.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-1,451.85
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%-100.0%
-
EPS growth Medical - Devices: +28.5%+57.1% ★ Q2'24: +25.0% (vs Q2'23)
-
FCF margin FCF growth · Medical - Devices: +30.9%—
-
EBIT margin Medical - Devices: +6.2%—
-
ROIC Medical - Devices: +3.3%— Q2'24: +27.2% (vs Q2'23)
-
Share dilution Medical - Devices: 0.0%+0.0% ★ Q2'24: +0.0% (vs Q2'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-0.05× Q2'24: -0.09× (vs Q2'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-107.1K
OE per share TTM
0.00
Owner's Yield
-957.41%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
7.5%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
1
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (: | 69.66M | 35.18% | 69.66M | — | 69.66M | 10.00 | IN | United States of America | 2004-02-12 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
4
Sells
0
Shares acquired
2.00M
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+2,000,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-06-30 | Theoharis Chris | Director / Officer | A-Award | A | Stock Options | 500,000 | 0.06 | 30.0K | 500,000 | — | ↗ |
| 2016-06-30 | SCHATZ LARRY H | Director | A-Award | A | Stock Options | 500,000 | 0.06 | 30.0K | 500,000 | — | ↗ |
| 2016-06-30 | Georgiou Photios Frank | Director | A-Award | A | Stock Options | 500,000 | 0.06 | 30.0K | 500,000 | — | ↗ |
| 2016-06-30 | Friedman Leonard | Director / Officer | A-Award | A | Stock Options | 500,000 | 0.06 | 30.0K | 500,000 | — | ↗ |
| 2015-09-24 | Theoharis Chris | Director / Officer | P-Purchase | A | Common Stock, $.001 par value | 20,000 | 0.11 | 2.1K | 4,445,334 | — | ↗ |
| 2015-09-08 | Georgiou Photios Frank | Director | P-Purchase | A | Common Stock, $.001 par value | 88,000 | 0.08 | 7.0K | 22,850,675 | — | ↗ |
| 2015-06-30 | Theoharis Chris | Director / Officer | A-Award | A | Stock Options | 500,000 | 0.08 | 40.0K | 500,000 | — | ↗ |
| 2015-06-30 | SCHATZ LARRY H | Director | A-Award | A | Stock Options | 500,000 | 0.08 | 40.0K | 500,000 | — | ↗ |
| 2015-06-30 | Georgiou Photios Frank | Director | A-Award | A | Stock Options | 500,000 | 0.08 | 40.0K | 500,000 | — | ↗ |
| 2015-06-30 | Friedman Leonard | Director / Officer | A-Award | A | Stock Options | 500,000 | 0.08 | 40.0K | 500,000 | — | ↗ |
| 2015-06-09 | Theoharis Chris | Director / Officer | P-Purchase | A | Common Stock, $.001 par value | 10,000 | 0.06 | 560.00 | 4,415,334 | — | ↗ |
| 2015-03-13 | SCHATZ LARRY H | Director | A-Award | A | Common Stock, $.001 par value | 1,000,000 | 0.09 | 90.0K | 5,000,000 | — | ↗ |
| 2014-06-30 | Tsoupanarias Emmanuel | Director / Officer | A-Award | A | Stock Options | 500,000 | 0.13 | 65.0K | 500,000 | — | ↗ |
| 2014-06-30 | Theoharis Chris | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-06-30 | SCHATZ LARRY H | Director | A-Award | A | Warrant | 2,500,000 | 0.12 | 300.0K | 2,500,000 | — | ↗ |
| 2014-06-30 | Georgiou Photios Frank | Director | A-Award | A | Stock Options | 500,000 | 0.13 | 65.0K | 500,000 | — | ↗ |
| 2014-06-30 | Friedman Leonard | Director / Officer | A-Award | A | Stock Options | 500,000 | 0.13 | 65.0K | 500,000 | — | ↗ |
| 2014-05-14 | SCHATZ LARRY H | Director | A-Award | A | Stock Options | 2,000,000 | 0.06 | 110.0K | 2,000,000 | — | ↗ |
| 2013-11-22 | Theoharis Chris | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2013-11-05 | MASLOW MARVIN | 10% Owner | — | D | Series D Preferred Stock | 19,229,273 | 10.00 | 192.29M | 0 | — | ↗ |
| 2013-07-23 | Theoharis Chris | Director | P-Purchase | A | Common Stock, $.001 par value | 20,000 | 0.04 | 720.00 | 3,648,365 | — | ↗ |
| 2013-06-19 | Georgiou Photios Frank | Director | P-Purchase | A | Common Stock, $.001 par value | 10,000 | 0.04 | 449.00 | 21,956,506 | — | ↗ |
| 2013-06-18 | Theoharis Chris | Director | P-Purchase | A | Common Stock, $.001 par value | 20,000 | 0.04 | 890.00 | 3,628,365 | — | ↗ |
| 2013-06-17 | Theoharis Chris | Director | P-Purchase | A | Common Stock, $.001 par value | 20,000 | 0.04 | 780.00 | 3,608,365 | — | ↗ |
| 2013-05-24 | Theoharis Chris | Director | P-Purchase | A | Common Stock, $.001 par value | 2,000 | 0.05 | 95.00 | 3,588,365 | — | ↗ |
| 2013-05-02 | Theoharis Chris | Director | P-Purchase | A | Common Stock, $.001 par value | 500 | 0.05 | 25.00 | 3,586,365 | — | ↗ |
| 2012-07-17 | Georgiou Photios Frank | Director | P-Purchase | A | COMMON STOCK | 117,600 | 0.05 | 6.2K | 21,917,706 | — | ↗ |
| 2012-06-18 | Georgiou Photios Frank | Director | P-Purchase | A | COMMON STOCK | 100,000 | 0.05 | 4.7K | 21,800,106 | — | ↗ |
| 2012-06-05 | Theoharis Chris | Director | P-Purchase | A | Common Stock, $.001 par value | 10,000 | 0.04 | 404.00 | 3,585,865 | — | ↗ |
| 2012-01-02 | Theoharis Chris | Director | S-Sale | D | Common Stock, $.001 par value | 435,395 | 0.06 | 23.9K | 3,575,865 | — | ↗ |
| 2011-11-03 | Theoharis Chris | Director | P-Purchase | A | Common Stock, $.001 par value | 10,000 | 0.07 | 650.00 | 4,011,260 | — | ↗ |
| 2011-10-31 | Theoharis Chris | Director | P-Purchase | A | Common Stock, $.001 par value | 10,000 | 0.07 | 685.00 | 4,001,260 | — | ↗ |
| 2011-10-27 | Theoharis Chris | Director | P-Purchase | A | Common Stock, $.001 par value | 10,000 | 0.07 | 670.00 | 4,190,500 | — | ↗ |
| 2011-08-06 | SCHATZ LARRY H | Director | A-Award | A | Common Stock, $.001 par value | 2,000,000 | 0.02 | 40.0K | 3,000,000 | — | ↗ |
| 2011-08-05 | Tsoupanarias Emmanuel | Director / Officer | A-Award | A | Stock Options | 5,000,000 | 0.07 | 350.0K | 5,000,000 | — | ↗ |
| 2010-06-07 | SCHATZ LARRY H | Director | — | D | Common Stock | 0 | 0.00 | — | 1,000,000 | — | ↗ |
| 2008-01-04 | MASLOW MARVIN | 10% Owner | — | D | Stock Options | 15,000,000 | 0.01 | 150.0K | 0 | — | ↗ |
| 2007-11-01 | Tsoupanarias Emmanuel | Director / Officer | — | I | Warrant | 800,000 | 0.01 | 10.4K | 0 | — | ↗ |
| 2007-10-11 | Theoharis Chris | Director | — | D | Warrant | 800,000 | 0.01 | 10.4K | 0 | — | ↗ |
| 2007-10-11 | MASLOW MARVIN | Officer / 10% Owner | A-Award | A | Warrant | 800,000 | 0.01 | 10.4K | 23,950,000 | — | ↗ |
| 2007-10-11 | Georgiou Photios Frank | Director | — | D | Common Stock | 0 | 0.00 | — | 9,200,106 | — | ↗ |
| 2007-10-11 | Friedman Leonard | Director | — | D | Warrant | 800,000 | 0.01 | 10.4K | 0 | — | ↗ |
| 2007-08-17 | MASLOW MARVIN | Officer / 10% Owner | G-Gift | D | Common Stock | 4,800,000 | 0.00 | — | 29,047,606 | — | ↗ |
| 2007-05-09 | TEICH DAVID | Director / Officer | A-Award | A | Common Stock | 6,250,000 | 0.02 | 125.0K | 10,000,000 | — | ↗ |
| 2007-05-09 | MASLOW MARVIN | Director / Officer / 10% Owner | A-Award | A | Common Stock | 14,200,106 | 0.01 | 71.0K | 33,847,606 | — | ↗ |
| 2006-05-04 | TEICH DAVID | Director / Officer | A-Award | A | Common Stock | 1,500,000 | 0.06 | 90.0K | 3,750,000 | — | ↗ |
| 2006-05-04 | MASLOW MARVIN | Director / Officer / 10% Owner | A-Award | A | Common Stock | 10,000,000 | 0.06 | 600.0K | 21,792,500 | — | ↗ |
| 2006-05-04 | ANDERSON RALPH | Director | A-Award | A | Common Stock | 1,500,000 | 0.06 | 90.0K | 3,000,000 | — | ↗ |
| 2005-06-03 | SCHATZ LARRY H | Director | A-Award | A | Common Stock | 250,000 | 0.00 | — | 1,500,000 | — | ↗ |
| 2004-12-30 | MASLOW MARVIN | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 100,000 | 0.00 | — | 12,380,000 | — | ↗ |
| 2004-12-13 | TEICH DAVID | Director / Officer | S-Sale | D | Common Stock | 6,500 | 0.07 | 422.50 | 2,250,000 | — | ↗ |
| 2004-12-10 | TEICH DAVID | Director / Officer | S-Sale | D | Common Stock | 10,064 | 0.07 | 654.16 | 2,263,000 | — | ↗ |
| 2004-07-10 | STEINBERG MARTY | 10% Owner | — | D | No securities beneficially owned | 0 | 0.00 | — | 0 | — | ↗ |
| 2004-06-25 | SCHATZ LARRY H | Director | S-Sale | D | Common Stock | 163,000 | 0.09 | 14.7K | 1,250,000 | — | ↗ |
| 2004-06-24 | SCHATZ LARRY H | Director | S-Sale | D | Common Stock | 100,000 | 0.09 | 9.0K | 1,413,000 | — | ↗ |
| 2004-06-22 | SCHATZ LARRY H | Director | S-Sale | D | Common Stock | 5,000 | 0.10 | 475.00 | 1,513,000 | — | ↗ |
| 2004-06-17 | SCHATZ LARRY H | Director | S-Sale | D | Common Stock | 87,000 | 0.11 | 9.6K | 1,518,000 | — | ↗ |
| 2004-06-16 | SCHATZ LARRY H | Director | S-Sale | D | Common Stock | 45,000 | 0.12 | 5.2K | 1,605,000 | — | ↗ |
| 2004-06-03 | SCHATZ LARRY H | Director | A-Award | A | Common Stock | 250,000 | 0.00 | — | 1,650,000 | — | ↗ |
| 2004-05-21 | BACH SCOTT | Director / Officer | M-Exempt | D | Stock Options | 1,000,000 | 0.02 | 20.0K | 0 | — | ↗ |
| 2003-06-03 | SCHATZ LARRY H | Director | A-Award | A | Stock Options | 500,000 | 0.05 | 25.0K | 1,000,000 | — | ↗ |
| 2003-06-03 | ANDERSON RALPH | Director | — | D | Common Stock | 0 | 0.00 | — | 1,000,000 | — | ↗ |
Executive team
Top executives
Shares Outstanding
559.28M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Robert Romeo Proulx | President of Imagion | 250.0K | male |
| Emmanuel Tsoupanarias | President, Chief Executive Officer & Director | 186.0K | male |
| Leonard C. Friedman | Secretary | — | male |
| Marvin Maslow | Founder & Chairman of the Board | — | male |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MHTX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
